A European study undertaken in horses to evaluate the efficacy of the key anthelmintic molecules fenbendazole, pyrantel, ivermectin and moxidectin in treating equine cyathostomins, has confirmed that resistance is developing against all the molecules with the exception of moxidectin.
Resistance to fenbendazole was highlighted as a particular issue with 80% of the yards tested in the UK and Germany showing resistance. Resistance to pyrantel also proved to be increasingly prevalent while cases of ivermectin resistance were emerging.
The Fort Dodge-sponsored study, the largest of its kind so far undertaken, took place during 2008 and was led by scientific teams from veterinary faculties in Italy and Germany. It was based on Faecal Egg Count Reduction Tests (FECRTs) of 1,704 horses at 102 yards in Italy, Germany and the UK. The calculation of FECR data was performed employing bootstrap analysis of group arithmetic means.
The study concluded that:
According to Dr Donato Traversa from the University of Teramo, Italy, who headed up the field work, the results confirm that single and even multiple drug resistance in equine cyathostomins is an increasing challenge in all three countries with resistance to fenbendazole and pyrantel a particular concern.
He said: "Our research highlights the necessity for vets, owners and managers to use those anthelmintic molecules that remain most effective in a manner which preserves their efficacy for as long as possible."
Professor Georg von Samson Himmelstjerna from Hannover University of Veterinary Medicine, which participated in the research, added: "Given the strong impact that resistant cyathostomins are likely to have on horse welfare, future parasite control plans should be based on integrated measures, involving both the correct use of anthelmintics, such as administering the correct dosing according to the animals weight, and only using products in the species for which it is licensed, as well as other approaches such as adequate pasture hygiene, low stocking rates and mixed grazing with other animals.
"We call on all concerned with equine health and welfare to take an active role in planning and monitoring effective worm control programs."
The Equine Veterinary Journal (EVJ) has published a free online collection of articles which explain the current understanding of equine antimicrobial resistance and how the profession can preserve the effectiveness of these essential medicines.
The new collection comprises ten clinical reports and studies and three editorials covering current trends on bacterial populations, risk factors and the appropriate use of antimicrobials in practice.
A clinical report on the changes in bacterial populations in foals with sepsis raises the question whether the emergence of resistance in horses has occurred as a result of antibiotic use in humans, with nosocomial spread from human handlers in foals. Studies on the prevalence of faecal carriage of antimicrobial resistant E. coli show their prevalence to be common in normal horses in the community in the UK, although MRSA carriage was rare. Data suggested transmission of resistant bacteria from animals receiving antibiotics may result in carriage of bacteria by in contact animals.
The need for judicious use of antimicrobials is reinforced in a study on antimicrobial-associated diarrhoea in three equine referral practices. Two papers investigate both prescribing practice in the UK and the impact of antimicrobial use on infection and pyrexia in hospitalised horses, concluding that there are opportunities for more targeted, ‘smart’, use antimicrobials in the perioperative period, rather than simply more antimicrobials.
The final study discusses a low-cost syndromic surveillance model for monitoring healthcare associated infection in clinical practice to provide a realistic benchmark against which other hospitals may compare antimicrobial study data.
Three supporting editorials complete the online collection, giving comment on the overall situation of antimicrobial resistance in the horses, including the current political situation and antimicrobials and surgical site infection.
Professor Peter Clegg, Associate Editor of the Equine Veterinary Journal said: "It remains to be determined how big a problem antimicrobial resistance will become for the equine veterinary profession, either through greater difficulties in treating horses, or through political pressure to restrict access to antimicrobials. Meanwhile the EVJ remains committed to the promotion of responsible stewardship to best preserve the efficacy of the drugs we have got for as long as we can."
Mark Bowen, President of the British Equine Veterinary Association and guest editor said: "BEVA has a long-term commitment to promoting responsible antimicrobial use throughout the profession and supporting EAAD through the PROTECT ME brand. This year we have released resources around Education, aimed at the profession through EVJ and to the horse owning public through development of material that can be provided alongside antimicrobial dispensing. The work of the equine profession in preserving the highest priority antimicrobials will ensure efficacy can be retained for as long as is possible."
The antimicrobial online collection is available free online at: http://onlinelibrary.wiley.com/journal/10.1001/(ISSN)2042-3306/homepage/antimicrobial_resistance.htm
For the project, the company has developed a Brachycephalic Obstructive Airway Syndrome (BOAS) clinical assessment tool which can be used by a vet or nurse in practice to make a diagnosis.
The assessment is a holistic one which includes taking a history of the animal, a full physical examination, an exercise test and an examination of the dog’s nostrils.
The results of the assessment are then discussed with the owner to agree on a course of treatment.
During each consultation, vets and nurses also look to talk sensitively with clients about breeding, buying and owning brachycephalic dog breeds, offering welfare advice on how to manage their dog’s lifestyle, including issues such as keeping their weight low and looking after them in hot weather.
CVS says it hopes this will increase a general level of welfare awareness amongst brachycephalic dog owners.
CVS has also created a collection of resources for its teams, including new clinical frameworks and veterinary guidelines, webinars and a CPD day on the subject.
The company has also created materials to help vets and nurses have what can be challenging discussions with clients, including consultation room posters and practice reception TV videos which showing the physiology of the brachycephalic breed.
CVS says that since launch in July last year, the 25 participating practices have conducted nearly 900 brachycephalic assessments, and it aims to have at least 5% of Pugs, French Bulldogs and Bulldogs undergoing assessment across its small animal division by 2028.
Ian, who qualified from Melbourne University in 2004 after completing a neuroscience degree at Edinburgh University, first joined Rowe as a general practitioner in 2007.
He said: “Personally this achievement is incredibly rewarding, but I also see it as an important step for veterinary neurology in the UK.
"It’s a fast-growing field with an increasing need for expert treatment and care so it’s exciting to see it recognised at this level.”
https://www.rowereferrals.co.uk
The Disciplinary Committee of the Royal College of Veterinary Surgeons last week ordered a month's suspension for a veterinary surgeon from Dolgellau for dishonest certification of bovine tuberculin testing in the Gwynedd area in early 2007.
At a hearing that concluded last Friday, Iwan Parry, a partner of The Veterinary Surgery, Bala Road, Dolgellau, and an Official Veterinarian, was charged with serious professional misconduct for certifying on eight separate occasions that he had tested and inspected cattle for clinical signs of bovine tuberculosis (TB), when he had not done so. At the outset of the hearing, Mr Parry denied the charges.
The Committee heard that Animal Health (a DEFRA Executive Agency) had discovered irregularities in TB testing paperwork from Mr Parry's practice. These included two locum veterinary surgeons, who were not Local Veterinary Inspectors (LVIs), having carried out TB pre-movement testing, but the relevant paperwork being signed and certified by Mr Parry. It therefore suspended him from LVI duties and lodged a complaint with the RCVS.
The Committee heard that, at the time, Mr Parry's practice was in difficulty as all eight of his assistant veterinary surgeons had recently left and he was struggling to maintain services. It was also reported that the incidence of bovine TB in Mr Parry's area was very low.
Under questioning, Mr Parry admitted that he had not done the testing, but had allowed non-LVI veterinary surgeons to do so and then signed the certificates himself. Denying the charge of dishonesty, he maintained that he had thought his actions were legitimate, providing he questioned the veterinary surgeons afterwards and checked their results. However, he told the Committee he now deeply regretted this "honest mistake", made at a time of great personal pressure, and that it would not be repeated.
The Committee also heard evidence from a number of character witnesses, including Mr Elfyn Llwyd MP, testifying to Mr Parry's good character, integrity and good standing in the local community and agricultural sector.
Nevertheless, in view of Mr Parry's long experience as an LVI, his understanding of the importance of routine herd testing and accurate veterinary certification and his reputation for keeping up to date with legislative and professional developments, the Committee decided that his actions were not just inappropriate, but were the result of conscious impropriety on his part. It found that he was not only guilty of dishonesty, but of allowing non-LVIs to perform TB testing, both of which amounted to serious professional misconduct.
In passing judgment, the Committee emphasised that the integrity of veterinary certification was of the utmost importance, especially when carried out on behalf of the Government, in order to safeguard animal health and facilitate international trade. It also felt that Mr Parry could not have failed to have been fully aware of what he was signing and that he should not have done so.
It was, however, prepared to take account of some exceptional mitigating factors in this case, including the low risk of TB spread following Mr Parry's actions; that no financial gain had been sought or received by him; his unblemished career and uprightness of conduct to date; the esteem in which he was held in the farming community and the potential (financial) impact on that community if he were to be removed from the Register (therefore unable to practise) for a significant period of time.
Nigel Swayne MRCVS, chairing the Disciplinary Committee, concluded: "We are reminded that the primary purpose of any sanction is not punishment, but the maintenance of public confidence in the profession and to uphold professional standards of conduct.
"Whilst only a reprimand is not an appropriate sanction where dishonesty and false certification have been found proved, and such findings would normally attract at least a long period of suspension, given the wholly exceptional circumstances of this case and the strength of the mitigating factors, we direct that Mr Parry should be suspended for one month."
Dairy vets will soon be receiving a DVD highlighting the economic losses due to coccidiosis in cattle, from Janssen Animal Health.
According to the company, coccidiosis is a major cause of scouring and poor growth rates in calves yet recent findings have demonstrated that a massive 61 per cent of the economic loss occurs in sub-clinically infected calves that are not showing any obvious clinical signs. Treated calves have been shown to put on 20 per cent more weight than untreated calves1. Coccidiosis infects between 16 and 27 per cent of adult cattle who act as reservoirs of the disease2,3,4,5. This means that most calves are likely to become exposed to the infectious form of the parasite. After the age of 6 months the majority of calves acquire immunity but if they are exposed to a massive challenge before that time due to large numbers of the coccidial oocysts or due to a stress factor, sub-clinical or clinical disease occurs.
The DVD describes the challenges involved in diagnosing coccidiosis and how to interpret faecal oocyst counts, as well as some of the characteristics of sub-clinical infection in calves. The benefits of metaphylactic and preventative approaches to treatment with Vecoxan®, the only anticoccidial drench licensed for beef and dairy cattle at any age, indoors and out, are discussed.
Nigel Underwood from Janssen Animal Health said: "The diagnosis of non-specific scour is problematic at best but it is important that vets have coccidiosis at front of mind when considering the differential diagnosis. Prompt treatment of the whole batch of calves can stop the disease in its tracks and does not interfere with the development of future immunity. We hope this DVD will provide an update on the latest thinking and help increase recognition of this disease."
The DVD will be sent out in February and any vet with an interest in the disease who does not received one before the end of the month should call Janssen on 01494 567555 to request a copy.
Further information is available from Janssen Animal Health, 50-100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG Tel 01494 567555 Fax 01494 567556 Email: ahealth@jacgb.jnj.com
References
A new award aims to ‘reward innovative and outstanding work' by a veterinarian, in the field of pain management in companion animals or horses.
The Merial Animal Health sponsored initiative was announced at a recent Pain Management Symposium held in Croatia.
Applications are now being invited for the first Merial European Pain Management Award. Case histories may relate to pain in connection with osteoarthritis, surgery, oncology or pain due to other causes.
Dr Frédéric Beugnet, technical director at Merial, Lyon explained: "The objective is to share knowledge for a better understanding, recognition, scoring and control of pain in companion animals."
Worth €3000 to the winner, the 2008 award will be presented at the 2009 Merial Pain Management Symposium to be held next spring. Applications should be made in English in an electronic format and include a short abstract (max. 500 words) of the work the applicant wishes to submit, a CV and a completed application form.
The deadline for submission is 1st November 2008. Application forms are available from Merial, please email: ukcompanionanimal@merial.com with "Merial Pain Management Award 2008" as the subject header.
Anyone unable to attend the latest in the increasingly popular BVA Animal Welfare Foundation discussion forums, held in May, can now catch up on the presentations on VETS.TV - the new web TV service currently being piloted by BVA - which can be accessed at www.vets.tv.
All the presentations, including ‘Put your money where your mouth is - can people afford animal welfare in food production', ‘Designer animals or breeding for welfare' and ‘Electric aid or shock collar' as well as the Norman Hayward Fund sponsored session - which included presentations on both the British Equine Veterinary Association (BEVA) and Edinburgh University laminitis studies and the casualty slaughter of sheep - along with the Chair of the BVA:AWF Trustees, Carl Padgett's summary of the day, are now available online to view at your convenience.
Also new on VETS.TV is an interview with Young Vet Network (YVN) senior graduate BVA Council representative, Louisa Rance who talks about the work of the YVN and how it is helping newly qualified vets with the challenges faced after leaving vet school and a series of videos, courtesy of Farmers Weekly, on Bluetongue - what it is, how it is transmitted, the symptoms and vaccination advice.
Recent changes in the way veterinary schools teach clinical and practical skills, coupled with increasing financial pressure on students and new graduates, have triggered the Royal College of Veterinary Surgeons to review its guidelines for Extra-Mural Studies (EMS) and clinical education.
A requirement has been in place for the last 75 years that veterinary students ‘see practice' for at least 26 weeks in their clinical years.
The purpose of EMS has always been to ensure that veterinary students have the right mix of practical and theoretical teaching and understand the realities of commercial clinical practice before they graduate. This objective does not change, but the College's Education Policy and Specialisation Committee believes it is now time to look again at what is covered in the clinical curriculum of the undergraduate degree to ensure that guidelines are kept up to date.
EMS was last reviewed in 1996, but in the interim veterinary schools have introduced new ways of teaching practical and clinical aspects of the curriculum. There has also been an increase in the role played by the veterinary schools' own first opinion practices.
In addition, having to carry out EMS not only restricts students' capacity to work during the holidays, but often incurs substantial travel and accommodation expenses. With students facing increasing amounts of debt, the financial impact of EMS needs to be reviewed.
The review group, which will be chaired by RCVS Council Member and practitioner Dr Barry Johnson, will gather evidence from a broad range of stakeholders. It aims to make a report to Council by the end of 2009.
The Federation of European Companion Animal Veterinary Associations (FECAVA) has launched the European Journal of Companion Animal Practitioners (EJCAP) Online, the first European fully online veterinary journal.
As the official journal of the FECAVA, the EJCAP online is exclusively available to members of national companion animal veterinary associations which are in turn members of FECAVA (which include the BSAVA).
According to FECAVA, the EJCAP online will continue to offer the sort of high quality CPD articles which the magazine was known for during its 21 year history in print. However it will now also be able to offer rich media, such as videos with clinical presentations, endoscopy and ultrasound recordings, diagnostic and surgical techniques, interviews with experts, conference presentations as well as slide shows, interactive quizzes, surveys and animations.
The frequency of publication has also been increased, from three to four issues per year, including one special issue.
The EJCAP online is available in two languages - English and Spanish. More languages are planned in future.
Simon Orr, FECAVA president, said: "Since the momentous decision to publish EJCAP online was taken by our Council in Lille in 2009, we are delighted to offer our members this new and engaging way to gain new information and skills.
As we start work on the next issues, we invite all our readers to give us feedback on this first volume of EJCAP online. On the last spread (page) there is a link to a survey on this new format, to help us further improve and optimize EJCAP online."
To register, visit EJCAP online (www.fecava.org/ejcap).
The RCVS has written to the MPs drawn in today's private members' Bill ballot to call upon them to introduce legislation to protect the title 'veterinary nurse' and introduce an effective regulatory system that would ensure that those veterinary nurses found guilty of serious professional misconduct are prevented from carrying out medical treatment to or surgery on animals.
Currently the title 'veterinary nurse' is not protected, so anyone can legally refer to themselves as a veterinary nurse, regardless of their level of training.
Furthermore, veterinary nurses (VNs) are not subject to statutory regulation; the RCVS uses powers under its Royal Charter to award certificates to VNs who have undergone approved training. Qualified VNs (whose names appear in a List of certificate-holders published by the RCVS) are allowed to give medical treatment to, or carry out minor surgery on, animals under the Veterinary Surgeons Act 1966 (VSA).
In 2007, the RCVS introduced a non-statutory Register of Veterinary Nurses. Registered veterinary nurses (RVNs) commit to follow a code of professional conduct, keep their skills and knowledge up to date and submit to a disciplinary system.
RVNs found guilty of serious professional misconduct can be suspended or removed from the Register at the direction of the RVN Disciplinary Committee (DC), but the RCVS has no power to remove them from the List. This means they can still legally give medical treatment or carry out minor surgery and perform other nursing duties specified under VSA (although they will then be formally listed as 'DC removal - Listed').
The RCVS has been working for some time to develop a framework for the regulation of veterinary nurses and has sent the ballot MPs a pre-prepared Bill, drafted by leading Counsel.
The statutory regulation of VNs is widely supported by the veterinary nursing profession and the public. This is evidenced by a 2012 HM Government e-petition, calling for the statutory regulation of veterinary nurses, which received over 2,500 signatures. Furthermore, the regulation of veterinary nurses by statute is supported by the British Veterinary Nursing Association and the British Veterinary Association, the representative bodies for veterinary nurses and surgeons in the UK.
RCVS Chief Executive Nick Stace said:"I urge MPs selected in today's Ballot to take forward legislation for the statutory regulation of veterinary nurses and the protection of the title veterinary nurse. The nation's animals and owners deserve better than the current situation.
"There is widespread support amongst the public and profession for such legislation, so the RCVS has had a Bill drafted by leading Counsel and is prepared to offer significant support to any MP willing to pick up this worthy cause."
The Evidence-Based Veterinary Medicine Learning Consortium has announced the launch of a new online tutorial (www.ebvmlearning.org) designed to make evidence-based veterinary medicine (EBVM) accessible to the veterinary profession worldwide.
The online tutorial, funded by the RCVS Knowledge Target Grants initiative and led by Dr Kristen Reyher at the University of Bristol along with Drs Rachel Dean and Marnie Brennan from the Centre for Evidence-based Veterinary Medicine at the University of Nottingham, begins with an introductory module and then focuses on the five key areas of EBVM:
The learning resource, which can be used on various platforms and devices, is suitable for students and practitioners for self-study, and can be used as a stand-alone tutorial or as individual teaching modules to support other EBVM teaching or continuing professional development.
The online tutorial uses best educational practice and includes formative multiple choice questions, short tasks and recommendations for further study. It is intended to be a source of knowledge, bringing together the essentials of EBVM into one place, and highlights many other links to resources and organisations that are available to further learners’ knowledge about the subject.
Dr Kristen Reyher, Senior Lecturer in Farm Animal Science in the School of Veterinary Sciences, who led the project team, said: "It is hoped that the development of this resource will increase awareness of EBVM in the veterinary profession, and allow practitioners the opportunity to develop the skills needed to utilise EBVM in everyday clinical practice."
Future aims of the project team include designing methods of cataloguing and disseminating evidence synthesis to support clinical decision-making and evidence-based veterinary practice, improving and standardising the teaching of EBVM to undergraduate and postgraduate students at veterinary schools internationally, and building a community of practice in this area.
Luisa (pictured left) said: “We want to further understand the research topics and questions that UK vets believe are most critical to improving veterinary care and advancing the veterinary profession.
“We are particularly interested in the topics, issues and questions that vets think scientific evidence would help when practicing veterinary medicine, whether specific to their role or the entire profession.
"It’s vitally important to highlight potential research gaps, so we can ensure clinical studies have the greatest possible impact to help improve outcomes for our patients.”
The survey will be conducted in two parts.
The first survey will close in early March, with the second survey circulated in April for three months.
The results will be published in an online, open access peer-reviewed journal.
Survey: https://bit.ly/4ko3utN
The studies and articles include a look at the importance of ethics, artificial Intelligence in veterinary practice, retention in the veterinary nursing profession, canine corneal bacterial pathogens, canine appendicular soft tissue sarcomas and mast cell tumours, and autologous mesenchymal stromal cell treatment.
Professor Luisa De Risio, Clinical Research and Excellence Director at Linnaeus, said: “Innovation in clinical research can only happen if we embrace change in society – from new technology to improvements in animal welfare. As well as showcasing the latest research, our new report also brings together experts to consider the opportunities for our profession.”
https://bit.ly/42KFrMK
The company says that the number of studies related to the dog and cat microbiome has increased by over 800% between 2012 and 20221, but that practical implementation of the research lags behind.
The event will cover topics ranging from nutrition and faecal microbial transplantation (FMT) for chronic enteropathy to controversies in the use of gastric acid suppressants and the roles of the gut-brain and gut-kidney axes in disease.
Speakers include Jan Suchodolski, MedVet, DrVetMed, PhD, AGAF, DACVM, who has published more than 340 peer-reviewed manuscripts in the field of veterinary gastroenterology and the microbiome, Kathrin Busch, DVM, Dr Med Vet, DECVIM-CA, Head of Small Animal Gastroenterology at Ludwig-Maximilians University, and Jessica Quimby, DVM, DACVIM (SAIM), PhD, International Renal Interest Society (IRIS) board member and winner of the IRIS Award 2018.
https://www.microbiomeforumevent2023.purinainstitute.com
Professor Susan Dawson (pictured right), Chair of the Mind Matters Taskforce, will introduce the event and will be followed by the symposium’s plenary speaker, Rory O’Connor, Professor of Health Psychology at the University of Glasgow and President of the International Association for Suicide Prevention.
Rory's talk: ‘When It is Darkest: Understanding Suicide Risk’ will draw upon his research and work on the psychological processes which precipitate suicidal behaviour and self-harm, an area of expertise that has seen him advise the Scottish Government, as well as other national and international organisations, on suicide prevention strategies.
The next presentation will be from Dr Victoria Crossley from the Royal Veterinary College and Navaratnam Partheeban, co-founder of the British Veterinary Ethnicity & Diversity Society (BVEDS), on their research into the mental health impact of racism and discrimination on Black, Asian and minority ethnic (BAME) veterinary surgeons.
They'll be followed by Professor Neil Greenberg and Dr Victoria Williamson from King’s College London, who will talk about their research into the impact of ‘moral injury’ on the mental health and wellbeing of vets.
The day will then split into different research streams with presentations on a variety of topics including: the impact of cyberbullying and harassment; the wellbeing of veterinary interns and residents; stigma and stress in veterinary nursing; mental health awareness training in the undergraduate veterinary curriculum; and the relationship between ‘patient safety culture’ and staff burnout.
Lisa Quigley, Mind Matters Manager, said: “As with previous years the Mind Matters Mental Health Research Symposium promises to be a very informative and important day in terms of international researchers coming together to share their research, their conclusions, areas for further work and study, and best practice.
"Some of the topics we will be discussing, such as suicide, will be difficult, but research into issues affecting the international veterinary community is a vital first step to putting in place strategies and support mechanisms to help those in need. This is why research will be one of the key strategic priorities for the Mind Matters Initiative and our forthcoming actions in this area will be published later this year in our Mind Matters Initiative Strategic Plan.
“I would like to thank Dr Rosie Allister, a veterinary mental health researcher from the University of Edinburgh and manager of Vetlife Helpline, for putting together an excellent programme.
"As with previous years we are also offering free attendance of the symposium to those who have lived experience of mental ill-health, those who are currently not working, and veterinary and veterinary nursing students. If you have any queries about the event, please don’t hesitate to contact me on l.quigley@rcvs.org.uk to discuss further.”
Registration for those not entitled to a free ticket is £10.
To register for the event visit: www.vetmindmatters.org/events.
Amy Bergs MRCVS, owner of The Cat Doctor in Surrey and co-founder of the new British Mobile Veterinary Association, has won a week's worth of free advertising for her practice on national TV.
The competition was run by the mobile payments company iZettle, which invited entrants to submit a 15 minute video about their business.
Amy's husband and business partner Robert put the video entry together. It was one of seven winners picked out of hundreds that iZettle said it received.
The resulting advert (below) is being shown on a number of TV channels, including Sky News, Sky Sports and Comedy Central, from today.
Amy said: "We are so excited to have won the competition. We love what we do and would like to help more cats, it’s such an amazing opportunity to share what we can offer on national television!"
watch?v=Vi8SCWcPJoo
European Specialist in Veterinary Dentistry Lisa Milella, who revealed last year that she has been diagnosed with motor neurone disease, has now announced that she plans to end her life at the Swiss-based organisation, Dignitas, and is calling on MPs to support a Private Members Bill on assisted dying, due for a second reading next month.
Speaking to the Daily Mail, Lisa said: "In Britain, we give more dignity in death to our pets than we do human beings. I don't want to suffer a prolonged, lingering death. I want to be able to choose when I die – and I'd like to do that in my home, surrounded by my loved ones with dignity – but British law doesn't allow me to do that and that makes me angry."
Meanwhile, Lisa's campaign to raise money for International Animal Rescue has smashed its original target of £10,000 and now stands at £24,096.83, with a new target of £50,000.
Labrador Retrievers are the breed most likely to run away, according to a survey of 2000 pet owners commissioned by the Blue Cross.
In addition, the survey found that the average dog owner has had their pet run off three times. One in five haven't had their dog microchipped and half of those say they probably won't ever have it done.
Only 23% of dog owners know it is already mandatory for dogs to wear a tag when in public, and only half of those knew the tag must bear the owner's name.
1/3rd thought the maximum fine for a dog being without a tag would be £100, when it is actually £5000.
The full list of breeds most likely to do a runner was:
The review coincided with a move last month from RUMA, the agricultural and food industry alliance which promotes responsible use of medicines in farm animals, to align with the EMA position.
The announcement means that under PVS guidelines, fluoroquinolones, 3rd and 4th generation cephalosporins and colistin will retain Class 3 status. This means they are only used when no other options are available and when supported by laboratory sensitivity testing – or exceptionally when all other options have failed.
Class 1 antibiotics form the standard prescribing list within responsible use guidelines and Class 2 are used only when sensitivity tests or clinical experience proves standard antibiotics are not effective. In all treatment decisions the health and welfare of the pigs must always take priority.
Betalactams with betalactamase inhibitors (clavulanic acid) were previously in the highest priority Class 3 but in light of the list defined by the EMA, which has been adopted by the Veterinary Medicines Directorate as well as RUMA, the PVS has reassessed the risk and moved them to Class 2 to align them with plain betalactams. This means they are still subject to voluntary restrictions, but their use would not necessarily be only as a last resort.
PVS president Mark White said that despite the ongoing review process and the potential to reclassify certain products, the Society’s underlying principles remain unchanged: "The total amount of all antibiotics used on pig farms to treat and prevent disease should be minimised, and the types of antibiotics used in pigs should be considered in light of the implications for antibiotic resistance challenges in both pigs and man.
"This policy is proving successful with AHDB Pork’s electronic pig medicine book (e-MB) recently showing that use of colistin appears to have fallen by over 70% in 2016 following its move to a Class 3 antibiotic in late 2015.
"We must also continue to be alert to the possibility of cross resistance, even in older antibiotics that have little or no use in humans. Risk must be acknowledged where it exists and overall reductions are still imperative."
RUMA has welcomed the review and alignment from the PVS. Secretary General John FitzGerald said: "Farmers and vets need boundaries within which to operate and clear objectives to meet, and we would urge all supply chains, from farmer to retailer, to align with the sector position on best practice use of antibiotics, as defined by each sector’s professional veterinary organisation."
Boehringer Ingelheim Vetmedica is giving veterinary practices the chance to offer cat owners a free 3ml pack of Metacam to trial treatment in cats with chronic pain.
Boehringer says each free Metacam pack will provide up to seven days' pain relief to an average-sized arthritic cat, and that it comes in an easy-to-administer cat friendly syringe for accurate dosing. The company also points towards a study which demonstrates that Metacam is highly palatable in 95% of cats1.
To qualify for the offer, veterinary surgeons have to fill in a redemption form logging five new cases. The offer is limited to 25 free bottles per practice. Replacement stock will be sent via your usual veterinary wholesaler. In addition, all completed forms will be entered into a prize draw to win one of six copies of the textbook 'Feline Orthopedics'
According to Boehringer, it is estimated that up to 90% of older cats (over 12 years of age) have radiographic evidence of degenerative joint disease2. However, cats may be more restrained than dogs in the way they react to chronic OA pain, and subtle behaviour changes can be a sign that cats are suffering from chronic pain3.
For further information on Metacam and the 3ml trial pack offer, contact your local Boehringer Ingelheim Vetmedica territory manager or telephone 01344 746959.
The BVA has announced that from 2013, its annual Congress will take place at the London Vet Show.
The association says that the move is being done to bring together political debate and clinical CPD on a large scale and to ensure that the BVA can reach an even wider audience with its representative and educational services.
The BVA and the Vet Show teamed up last year at London Vet Show 2011 to announce the launch of the BVA Careers Fair, which will be hosted at this year's London Vet Show on 15-16 November, and the start of a partnership that would ensure discounted Vet Show rates for BVA members.
2013 will also see two new clinical streams added to the London Vet Show programme creating a comprehensive CPD event for vets in small and mixed practice. Cattle and equine streams for mixed practitioners will be delivered by the BVA to run alongside the popular companion animal stream provided by the Royal Veterinary College.
The partnership will also see substantial discounts being offered to BVA members.
BVA President Carl Padgett said: "BVA's number one value is that our members are at the heart of everything we do. We know that members require good value, high quality and relevant CPD and we believe that our new partnership with the London Vet Show offers the best opportunity for us to provide members with exactly what they want.
"It's a significant move for BVA but one that makes complete sense. From 2013 we will be bringing together the contentious issue streams that are the bedrock of BVA Congress, with a high quality clinical CPD programme covering large and small animals, and one of the biggest and best veterinary exhibitions.
"We know we haven't attracted the delegate numbers we would like to have done in recent years and by partnering with the London Vet Show we have the opportunity to reach a much greater audience. It's a very exciting step forward for BVA."
Rob Chapman, Event Director for the London Vet Show, said: "We are all delighted to be developing our relationship with the BVA. To be able to host such an established and prestigious event as the BVA Congress at the London Vet Show is an honour for the Vet Show.
"Combining the long-standing history of the BVA with the rapidly developing reputation of the Vet Show gives us a great symbiotic relationship. The new clinical content that we will be working on together will help the event and that relationship even further offering great value for both Vet Show delegates and BVA members."